Psychiatry and Neurology, Neurology · Armonk, NY
NPI
1043380603
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
99 Business Park Dr
Armonk, NY, 10504
Phone (914) 681-1149
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
404 services
Medicare patients, 2024
77
Average age 68
Drug cost, 2024
$3.1M
1,104 prescriptions
Company payments, 2025
$265
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ute Traugott was code 99215 (office e&m - established), 179 times for 71 patients. In total Ute Traugott billed 404 services in 8 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 179 | 71 | $154.51 | $28K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 179 | 73 | $15.40 | $2,756 |
| 99214 Office E&M - Established | Office | 22 | 22 | $119.71 | $2,634 |
By year: 2022 $38K for 256 services; 2023 $32K for 234 services; 2024 $36K for 404 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ute Traugott prescribed most often to Medicare patients was Baclofen, with 85 prescriptions and refills. In total Ute Traugott wrote 1,104 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 85 | 137 | 20 | $1,695 |
| Tizanidine Hcl Generic | 85 | 121 | 17 | $1,804 |
| Kesimpta Pen Ofatumumab | 79 | 83 | Under 11 | $841K |
| Dalfampridine Er Dalfampridine | 66 | 66 | Under 11 | $7,376 |
| Copaxone Glatiramer Acetate | 62 | 69 | Under 11 | $380K |
| Nortriptyline Hcl Generic | 60 | 88 | Under 11 | $1,029 |
| Teriflunomide Generic | 58 | 58 | Under 11 | $84K |
| Betaseron Interferon Beta-1b | 55 | 59 | Under 11 | $600K |
| Gabapentin Generic | 53 | 75 | 11 | $669 |
| Methenamine Hippurate Generic | 51 | 75 | Under 11 | $3,280 |
| Aubagio Teriflunomide | 42 | 42 | Under 11 | $388K |
| Glatopa Glatiramer Acetate | 42 | 42 | Under 11 | $101K |
| Glatiramer Acetate Generic | 36 | 36 | Under 11 | $57K |
| Amantadine Amantadine Hcl | 35 | 49 | Under 11 | $1,609 |
| Rebif Interferon Beta-1a/Albumin | 33 | 33 | Under 11 | $318K |
Brand drugs: 317 claims; generic drugs: 787 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ute Traugott $265 ($265 in general payments such as food, travel and fees) from 2 companies. The largest payer was Genentech USA, Inc. with $150.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.